BioSpace News Archive

NANO-X IMAGING LTD, an innovative medical imaging technology company, announces that Nanox’s Chairman and Chief Executive Officer Ran Poliakine will make a company presentation and the leadership team will host investor 1x1 meetings during the Jefferies Virtual Healthcare Conference, which is being held June 1st through June 4th.

Company advances final validation efforts of its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

NeuraLace Medical, Inc., a medical device company focused on improving pain relief among patients suffering from debilitating chronic nerve pain, announced today that the first patient has been enrolled as part of the AXON-RCT U.S. study: a prospective, randomized, controlled clinical trial comparing the safety and effectiveness of Axon Therapy®

enGene Inc., a clinical-stage biotechnology company developing non-viral gene therapies for local administration into mucosal tissues enabled by its proprietary DDX platform, today announced the dosing of the first patient in the LEGEND study, a first-in-human Phase 1/2 clinical trial of EG-70 in patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).

Precision Genetics Inc. is making its first foray into providing their health products through the world’s largest testing marketplace, announcing today that it will be offering its Precision Mental HealthRx Solution for pharmacogenetics (PGx) testing nationwide with Meenta, Inc.

OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) and the FoRT Foundation (Fondazione Ricerca Traslazionale) today announced that the Italian Medicines Agency (AIFA) and the Italian Ethics Committee approved the initiation of a new Phase 2 clinical trial evaluating Tedopi® in combination with Opdivo® or chemotherapy as second-line treatment in patients with metastatic non-small cell lung cancer (NSCLC).

All of the shares of common stock are being offered by the Company.

Olympus Corporation of the Americas announced successful completion of a first use case of the 510 cleared e-ORTHO Shoulder software created by FH ORTHO, a company that Olympus acquired in November 2020.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

Innovation Collective and AARP Innovation Labs launch the Better Aging Through Technology Pitch Competition, for companies, early-stage startups, and ideas that improve our quality of life as we age.